Diverging prognostic effects of CD155 and CD73 expressions in locally advanced triple-negative breast cancer

Diverging prognostic effects of CD155 and CD73 expressions in locally advanced triple-negative breast cancer

BackgroundImmune checkpoint inhibition, combined with novel biomarkers, may provide alternative pathways for treating chemotherapy-resistant triple-negative breast cancer (TNBC). This study investigates the expression of new immune checkpoint receptors, including CD155 and CD73, which play a role in...

Full description

Bibliographic Details
Main Authors: Neslihan Cabioglu, Aysel Bayram, Selman Emiroglu, Semen Onder, Huseyin Karatay, Gizem Oner, Mustafa Tukenmez, Mahmut Muslumanoglu, Abdullah Igci, Adnan Aydiner, Pinar Saip, Ekrem Yavuz, Vahit Ozmen
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-07-01
Series:Frontiers in Oncology
Subjects:
CD155
CD73
chemotherapy response
prognosis
triple-negative breast cancer
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1165257/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1165257/full

Similar Items